Monogram Orthopaedics Inc. Common Stock
As of October 7, 2025, Monogram Technologies Inc. was acquired by Zimmer Biomet Holdings, Inc.. Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and ot… Read more
Monogram Orthopaedics Inc. Common Stock (MGRM) - Net Assets
Latest net assets as of June 2025: $8.62 Million USD
Based on the latest financial reports, Monogram Orthopaedics Inc. Common Stock (MGRM) has net assets worth $8.62 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($15.00 Million) and total liabilities ($6.38 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $8.62 Million |
| % of Total Assets | 57.45% |
| Annual Growth Rate | N/A |
| 5-Year Change | 190.67% |
| 10-Year Change | N/A |
| Growth Volatility | 98.61 |
Monogram Orthopaedics Inc. Common Stock - Net Assets Trend (2017–2024)
This chart illustrates how Monogram Orthopaedics Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Monogram Orthopaedics Inc. Common Stock (2017–2024)
The table below shows the annual net assets of Monogram Orthopaedics Inc. Common Stock from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $14.50 Million | +8.26% |
| 2023-12-31 | $13.40 Million | +222.88% |
| 2022-12-31 | $4.15 Million | +18.44% |
| 2021-12-31 | $3.50 Million | -29.79% |
| 2020-12-31 | $4.99 Million | +1916.77% |
| 2019-12-31 | $-274.63K | +80.26% |
| 2018-12-31 | $-1.39 Million | -105.22% |
| 2017-12-31 | $-677.81K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Monogram Orthopaedics Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6730700700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $35.00K | 0.24% |
| Other Components | $82.46 Million | 568.54% |
| Total Equity | $14.50 Million | 100.00% |
Monogram Orthopaedics Inc. Common Stock Competitors by Market Cap
The table below lists competitors of Monogram Orthopaedics Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hefei Department Store Group Co Ltd
SHE:000417
|
$183.52 Million |
|
SANIONA AB (PUBL)
F:30S
|
$183.59 Million |
|
Tianjin Motimo Membrane Tech
SHE:300334
|
$183.70 Million |
|
Selvas Ai Inc.
KQ:108860
|
$183.73 Million |
|
Bonava AB (publ)
ST:BONAV-B
|
$183.49 Million |
|
Mayne Pharma Group Limited
PINK:MAYNF
|
$183.45 Million |
|
Seven West Media Limited
PINK:WANHY
|
$183.39 Million |
|
Guangdong PAK Corporation Co Ltd
SHE:300625
|
$183.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Monogram Orthopaedics Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 13,397,066 to 14,503,000, a change of 1,105,934 (8.3%).
- Net loss of 16,328,000 reduced equity.
- Share repurchases of 200,000 reduced equity.
- New share issuances of 16,321,000 increased equity.
- Other factors increased equity by 1,312,934.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-16.33 Million | -112.58% |
| Share Repurchases | $200.00K | -1.38% |
| Share Issuances | $16.32 Million | +112.54% |
| Other Changes | $1.31 Million | +9.05% |
| Total Change | $- | 8.26% |
Book Value vs Market Value Analysis
This analysis compares Monogram Orthopaedics Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.48x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $-0.02 | $6.00 | x |
| 2018-12-31 | $-0.04 | $6.00 | x |
| 2019-12-31 | $-0.01 | $6.00 | x |
| 2020-12-31 | $0.17 | $6.00 | x |
| 2021-12-31 | $0.12 | $6.00 | x |
| 2022-12-31 | $0.14 | $6.00 | x |
| 2023-12-31 | $0.60 | $6.00 | x |
| 2024-12-31 | $0.45 | $6.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Monogram Orthopaedics Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -112.58%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.23x
- Recent ROE (-112.58%) is above the historical average (-133.02%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-591.21K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-573.17K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.77 Million |
| 2020 | -181.74% | -1443.38% | 0.08x | 1.63x | $-9.57 Million |
| 2021 | -337.27% | -1880.63% | 0.07x | 2.49x | $-12.17 Million |
| 2022 | -329.97% | 0.00% | 0.00x | 3.30x | $-14.11 Million |
| 2023 | -102.60% | -3765.81% | 0.02x | 1.24x | $-15.08 Million |
| 2024 | -112.58% | 0.00% | 0.00x | 1.23x | $-17.78 Million |
Industry Comparison
This section compares Monogram Orthopaedics Inc. Common Stock's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Monogram Orthopaedics Inc. Common Stock (MGRM) | $8.62 Million | 0.00% | 0.74x | $183.49 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |